SlideShare ist ein Scribd-Unternehmen logo
1 von 30
Who’s Who in International
        Malaria Control


Peace Corps Malaria Initiative for Africa
             Boot Camp

           DEBBIE GUEYE
           PMI/SENEGAL
         RESIDENT ADVISOR
              FEBRUARY 7, 2012
Objectives

 Understand how the different components of PMI
  (USAID, HHS, CDC) work together and with other
  agencies;
 Be familiar with the major international actors in
  malaria control
 Understand how the Global Fund application
  process works
 Discuss challenges and opportunities in coordination
The Major Actors

 President’s Malaria Initiative
 The Global Fund
 Roll Back Malaria Partnership
 World Health Organization/Global Malaria Program
President’s Malaria Initiative

 Launched in June 2005 as a five-year, $1.2 billion
  initiative to rapidly scale up malaria prevention and
  treatment interventions
 2008 Lantos-Hyde Act: funding extended through Fiscal
  Year 2014
 Managed by USAID in coordination with the Department
  of Health and Human Services (CDC), the Department of
  State, and the White House
 17 Countries: Angola, Benin, DRC, Ethiopia, Ghana,
  Kenya, Liberia, Madagascar, Malawi, Mali, Mozambique,
  Nigeria, Rwanda, Senegal, Tanzania, Uganda, Zambia
                      www.pmi.gov
PMI Principles

 PMI aligns its activities with host country malaria control
  strategies and coordinates closely with international partners,
  non-governmental organizations, community groups, and the
  private sector
 PMI is a core component of the Global Health Initiative (GHI),
  along with HIV/AIDS, and tuberculosis.
 Adherence to GHI core principles
 • encouraging country ownership      • increasing impact and efficiency
   and investing in country-led plans   through strategic coordination
   and health systems                   and programmatic integration
 • strengthening and leveraging key   • implementing a woman- and girl-
   partnerships, multilateral           centered approach
   organizations, and private
   contributions
 • improving monitoring and           • promoting research and
   evaluation                           innovation
PMI Goal and Interventions

 Goal: reduce malaria-related mortality by 70% in the original 15
  countries by the end of 2015, by reaching 85% of the most
  vulnerable groups – primarily pregnant women and children
  under five years old – with proven preventive and therapeutic
  interventions
 PMI supports four key intervention strategies for malaria
  prevention and control:
   Spraying approved, long-lasting insecticides on the interior walls
    of homes (indoor residual spraying)
   Promotion and distribution of long-lasting insecticide-treated
    bednets (LLINs)
   Training for medical personnel and community health workers to
    improve malaria diagnosis and effective treatment
   Prevention among pregnant women with prophylactic drugs
    during prenatal care (intermittent preventive treatment)
PMI Country Operations

 2 Resident Advisors in-country: USAID and CDC
     Provide technical support to NMCP and oversee PMI-funded
      programs
 Annual Malaria Operational Plan (MOP)
   Developed collaboratively with NMCP and local stakeholders

   Background, progress, planned activities

   Budget by activity and implementing mechanism

   Reviewed and approved by USAID-CDC Technical Working
    Group (TWG), followed by inter-agency steering group (ISG)
    that includes HHS, OMB, White House
   Any proposed changes must be described in reprogramming
    memo, approved by PMI Coordinator
PMI Country Operations

 Implementation mechanisms
   Bilateral: conceived, funded and managed from the local
    USAID Mission
   Field Support: conceived by USAID/Washington, some central
    funding and overall management; countries “buy in” and
    manage local interventions
 Funds allocated through competitive bidding
  processes
 Projects generally run 5 years
 Advance planning for funds that are slow to come
The Global Fund to Fight AIDS,
          Tuberculosis and Malaria

 Created in 2002 to dramatically increase resources to fight three
  of the world's most devastating diseases, and to direct those
  resources to areas of greatest need
 Partnership between governments, civil society, the private sector
  and affected communities represents an innovative approach to
  international health financing
 Model based on the concepts of country ownership and
  performance-based funding, which means that people in
  countries implement their own programs based on their priorities
  and the Global Fund provides financing on the condition that
  verifiable results are achieved

                   http://www.theglobalfund.org
Global Fund Guiding Principles

 Operate as a financial instrument, not an implementing entity

 Make available and leverage additional financial resources

 Support programs that evolve from national plans and
  priorities
 Operate in a balanced manner in terms of different regions,
  diseases and interventions
 Pursue an integrated and balanced approach to prevention and
  treatment
 Evaluate proposals through independent review process (TRP)

 Operate with transparency and accountability
Global Fund Core Structures - Central

 Global Fund Secretariat:
    manages the grant portfolio, including screening
     proposals submitted, issuing instructions to disburse
     money and implementing performance-based funding of
     grants
    tasked with executing Board policies; resource
     mobilization; providing strategic, policy, financial, legal
     and administrative support; and overseeing monitoring
     and evaluation
    based in Geneva, no staff located outside its headquarters
Global Fund Core Structures - Central

 Technical Review Panel (TRP):
    independent group of international experts in the three
     diseases and cross-cutting issues (health systems, M&E,
     etc.)
    meets regularly to review proposals based on technical
     criteria and provide funding recommendations to the Board
Global Fund Core Structures - Central

 Global Fund Board
    composed of representatives from donor and recipient
     gov-ernments, civil society, the private sector, private foundations,
     and communities living with and affected by the diseases
    responsible for the organization’s gover­nance, including
     establishing strategies and policies, making funding decisions and
     setting budgets
    works to advocate and mobilize resources for the organization

 Global Fund Trustee
    manages the organization’s money, which includes making
     payments to recipients at the instruction of the Secretariat
    The Trustee is cur-rently the World Bank
Global Fund Core Structures - Country

 Country Coordinating Mechanism (CCM)
    com-posed of all key stakeholders for the three diseases.
    Demonstrates commitment to local ownership and
     participatory decision-making
    includes representatives from public and private
     sectors, including governments, multilateral or bilateral
     agencies, non-governmental organizations, academic
     institutions, private businesses and people living with the
     diseases
    does not handle Global Fund financing itself
Global Fund Core Structures - Country

 CCM Core Functions
    coordinate the development and submission of national
     proposals
    nominate the Principal Recipient
    oversee implementation of the approved grant and submit
     requests for funding
    approve any reprogramming and submit requests for
     continued funding
    ensure linkages and consistency between Global Fund
     grants and other national health and development
     programs
Global Fund Core Structures - Country

 The Global Fund signs a legal grant agreement with a
 Principal Recipient (PR)
    designated by the CCM
    receives Global Fund financing directly, and uses it to
     implement prevention, care and treatment programs or
     passes it on to other organizations (sub-recipients) who
     provide those services
    makes regular requests for additional disbursements from
     the Global Fund based on demonstrated progress towards
     the intended results
Global Fund Core Structures - Country

 Local Fund Agents (LFAs)
    firms contracted by Global Fund to monitor
     implementation (selected through competitive bidding)
    responsible for provid-ing recommendations to the
     Secretariat on the capacity of the entities chosen to man-age
     Global Fund financing and on the soundness of regular
     requests for the disburse-ment of funds and result reports
     submitted by PRs.
Operations

 Annual call for proposals (“rounds”)
 GF follows the principles of performance-based funding
  in making funding decisions. Ensure that investments are
  made only where grant funding is managed and spent
  effectively on programs that achieve impact
 Grants initially approved for two years (Phase 1) and
  renewed for up to three additional years (Phase 2) based
  on performance
 Funding disbursed incrementally every three to six
  months throughout the grant's lifespan, and each
  disbursement is based on performance
High Level Independent Review Panel Recommendations

1. Turn the Page from Emergency to Sustainable Response
  1.1 No Amnesty for Fraud, but Focus Oversight on More-Recent Rounds of
  Grants
  1.2 Strengthen the Relationship between the Secretariat and the Inspector
  General
2. Declare a Doctrine of Risk and Manage to it
  2.1 Adopt a New Risk-Management Framework
  2.2 Redefine “Country Ownership”
  2.3 Apply the Risk-Management Framework to the Existing Portfolio
3. Strengthen Internal Governance
  3.1 Focus the Global Fund’s Board on Management, Strategy and Risk-
  Management
  3.2 Re-purpose the Committees (Investment, Audit, Finance)
  3.3 Create an Executive Staff to Support the Global Fund’s Board
High Level Independent Review Panel Recommendations (2)

4. Streamline the Grant-Approval Process
  4.1 Institute a Two-Stage Grant Process
  4.2 Apply Risk-Differentiated Grant Processes and Requirements
5. Empower Middle-Management’s Decision-Making
  5.1 Establish a Chief Risk Officer
  5.2 Align the Staffing Pattern to Bolster Grant-Management
  5.3 Empower the Fund Portfolio Managers
  5.4 Streamline and Expand the Country Teams
  5.5 Reinforce the Executive Management Team
  5.6 Leverage the Investment in the Local Fund Agents
  5.7 Define and Clarify the Role and Responsibilities of External Auditors
6. Get Serious About Results
  6.1 Measure Outcomes, Not Inputs
  6.2 Focus on Quality and Value, Rather than Quantity
  6.3 Consolidate the Reform Agenda
Roll Back Malaria (RBM) Partnership

 Lead international forum for malaria stakeholders to
  coordinate implementation activity, formulate and promote
  international policy positions relating to malaria, and to
  promote advocacy for malaria prevention, control, and fund-
  raising.
 Launched in 1998 by WHO, UNICEF, UNDP and the World
  Bank, in an effort to provide a coordinated global response to
  the disease.
 Led by the Executive Director, and served by a Secretariat that
  is hosted by the World Health Organization in Geneva. The
  Secretariat works to facilitate policy coordination at a global
  level.
            http://www.rollbackmalaria.org
Global Coordination

 The RBM Partnership is the global framework to implement
  coordinated action against malaria
     mobilizes for action and resources and forges consensus among
      partners
     is comprised of more than 500 partners, including malaria endemic
      countries, their bilateral and multilateral development partners, the
      private sector, nongovernmental and community-based
      organizations, foundations, and research and academic institutions
 RBM’s overall strategy aims to reduce malaria morbidity and
  mortality by reaching universal coverage and strengthening health
  systems. The Global Malaria Action Plan defines two stages of
  malaria control: (1) scaling-up for impact (SUFI) of preventive and
  therapeutic interventions, and (2) sustaining control over time.
RBM Organization

 Working Groups                        RBM Sub-Regional Networks
    Malaria Advocacy                    (SRNs):
    Communication
                                            Central Africa
    Harmonization: The HWG
     facilitates and harmonizes             East Africa
     partners' support in response
     to countries identified needs          Southern Africa
     and supports the
     establishment of the 'three            West Africa
     ones' principles for malaria at
     country level.                     Identify, coordinate, and
    Resources                           respond to requests for
    Vector Control                      technical assistance for the
    Procurement and Supply              scale-up of malaria control
     Management
                                         and treatment interventions
    Case Management
    Monitoring and Evaluation
    Malaria in Pregnancy
World Health Organization/
       Global Malaria Program (GMP)

 Responsible for malaria surveillance, monitoring and
 evaluation, policy and strategy formulation, technical
 assistance, and coordination of WHO's global efforts to
 fight malaria
 As part of the World Health Organization, convenes
 experts to review evidence and set global policies
 GMP's policy advice provides the benchmark for national
 malaria programmes and multilateral funding agencies

                 www.who.int/malaria
GMP Strategic Advantage

 Unique position uniting high levels of expertise – and
  WHO's field presence in all regions and all malaria-
  endemic countries of the world – ensures harmonized
  policy advice and the critical technical assistance necessary
  to effect concrete and sustainable successes at global level
 Activities focused on providing an integrated solution to the
  various epidemiological and operational challenges
 Promotes sound, evidence-based and locally appropriate
  strategies.
 Helps countries reach the most vulnerable populations and
  ensure that needed interventions take into account social,
  economic and environmental realities.
GMP Technical Assistance

 Supports national malaria programmes worldwide and provides
  technical assistance at country level on five main topics:
     diagnosis and treatment (diagnostic tools, medicines, patient
      management, quality assurance, supply chain management)
     vector control and preventive measures (mosquito control; reducing the
      risk of infection for local populations and international travellers)
     elimination of malaria (expanding the malaria-free areas of the world)
     surveillance, monitoring and evaluation (generating data for decision
      making, quality assurance)
     research (improving the tools to combat malaria, and the way we use
      them)
 Malaria National Professional Officer (NPO) in country offices
 WHO/AFRO: regional headquarters in Brazzaville, Congo
Key Technical Documents/Reports

 World Malaria Report
 Malaria Treatment Guidelines
 Anitmalarial efficacy and drug resistance: 2000-2010
 Global Plan for Artemisinin Resistance Containment
 Good Procurement Practices for Artemisinin-based
  antimalarial medicines
 Good Practices for Selecting and Procuring Rapid
  Diagnostic Tests for Malaria
 RDT Product Testing Results
 Indoor Residual Spraying
WHOPES (WHO Pesticide Evaluation Scheme)

 Set up in 1960, WHOPES promotes and coordinates the testing
    and evaluation of pesticides for public health
   Representatives of governments, manufacturers of pesticides and
    pesticide application equipment, WHO Collaborating Centres
    and research institutions, and other WHO programmes
   Four-phase evaluation and testing programme, studying the
    safety, efficacy and operational acceptability of public health
    pesticides and developing specifications for quality control and
    international trade
   WHOPES collects, consolidates, evaluates and disseminates
    information on the use of pesticides for public health.
   Recommendations facilitate the registration of pesticides by
    Member States.
Challenges and Opportunities in Coordination

 Among these actors, PMI is only one that has both money
 and people on the ground
    Global Fund: money, no people
    RBM: people (but regional focus), no money
    WHO: people, no money
 WHO is the technical leader for malaria control
  programs, personnel very well respected
 Global Fund: It’s complicated
 Objective: to have all partners supporting the NMCP plan
  and strategies
 Challenge: partners have their own agendas

Weitere ähnliche Inhalte

Was ist angesagt?

NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMMENATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMMEMAHESWARI JAIKUMAR
 
National Vector Borne Disease Control Programme (NVBDCP)
 National Vector Borne Disease Control Programme (NVBDCP) National Vector Borne Disease Control Programme (NVBDCP)
National Vector Borne Disease Control Programme (NVBDCP)Kailash Nagar
 
WHO Global Technical Strategy for Malaria 2016-2030
WHO Global Technical Strategy for Malaria 2016-2030WHO Global Technical Strategy for Malaria 2016-2030
WHO Global Technical Strategy for Malaria 2016-2030Shaan Ahmed
 
Planning for malaria elimination
Planning for malaria eliminationPlanning for malaria elimination
Planning for malaria eliminationNajibullah Safi
 
Lymphatic filariasis in nepal
Lymphatic filariasis in nepalLymphatic filariasis in nepal
Lymphatic filariasis in nepalAnju sapkota
 
IVM Toolkit_English_SEPTEMBER30-2016
IVM Toolkit_English_SEPTEMBER30-2016IVM Toolkit_English_SEPTEMBER30-2016
IVM Toolkit_English_SEPTEMBER30-2016Adrian Connelly
 
National Vector Borne Disease Control Programme
National Vector Borne Disease Control ProgrammeNational Vector Borne Disease Control Programme
National Vector Borne Disease Control ProgrammeDrAnup Kumar
 
National vector borne disease control programme 2 by nitin verma
National vector borne disease control programme 2 by nitin vermaNational vector borne disease control programme 2 by nitin verma
National vector borne disease control programme 2 by nitin vermaKartikesh Gupta
 
Malaria control in india
Malaria control in indiaMalaria control in india
Malaria control in indiaVijay Kumar
 
National Malaria Control Program and Strategy Nepal
National Malaria Control Program and Strategy NepalNational Malaria Control Program and Strategy Nepal
National Malaria Control Program and Strategy NepalDr.Sharad H. Gajuryal
 
Malaria elimination framework 2016 2030
Malaria elimination framework 2016 2030Malaria elimination framework 2016 2030
Malaria elimination framework 2016 2030DrSridevi NH
 
ANTI MALARIA CONTROL PROGRAMME
ANTI MALARIA CONTROL PROGRAMMEANTI MALARIA CONTROL PROGRAMME
ANTI MALARIA CONTROL PROGRAMMEChristyMary2
 

Was ist angesagt? (20)

NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMMENATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
 
National Vector Borne Disease Control Programme (NVBDCP)
 National Vector Borne Disease Control Programme (NVBDCP) National Vector Borne Disease Control Programme (NVBDCP)
National Vector Borne Disease Control Programme (NVBDCP)
 
Malaria Control Program in Nepal
Malaria Control Program in NepalMalaria Control Program in Nepal
Malaria Control Program in Nepal
 
NVBDCP---- Dr.Himanshusinh
NVBDCP---- Dr.HimanshusinhNVBDCP---- Dr.Himanshusinh
NVBDCP---- Dr.Himanshusinh
 
Malaria in nepal
Malaria in nepalMalaria in nepal
Malaria in nepal
 
WHO Global Technical Strategy for Malaria 2016-2030
WHO Global Technical Strategy for Malaria 2016-2030WHO Global Technical Strategy for Malaria 2016-2030
WHO Global Technical Strategy for Malaria 2016-2030
 
NVBDCP
NVBDCPNVBDCP
NVBDCP
 
national vector born disear
national vector born disear national vector born disear
national vector born disear
 
Planning for malaria elimination
Planning for malaria eliminationPlanning for malaria elimination
Planning for malaria elimination
 
Lymphatic filariasis in nepal
Lymphatic filariasis in nepalLymphatic filariasis in nepal
Lymphatic filariasis in nepal
 
Malaria control
Malaria controlMalaria control
Malaria control
 
IVM Toolkit_English_SEPTEMBER30-2016
IVM Toolkit_English_SEPTEMBER30-2016IVM Toolkit_English_SEPTEMBER30-2016
IVM Toolkit_English_SEPTEMBER30-2016
 
National Vector Borne Disease Control Programme
National Vector Borne Disease Control ProgrammeNational Vector Borne Disease Control Programme
National Vector Borne Disease Control Programme
 
National vector borne disease control programme 2 by nitin verma
National vector borne disease control programme 2 by nitin vermaNational vector borne disease control programme 2 by nitin verma
National vector borne disease control programme 2 by nitin verma
 
Malaria control in india
Malaria control in indiaMalaria control in india
Malaria control in india
 
National Malaria Control Program and Strategy Nepal
National Malaria Control Program and Strategy NepalNational Malaria Control Program and Strategy Nepal
National Malaria Control Program and Strategy Nepal
 
NVBDCP-GUJARAT
NVBDCP-GUJARATNVBDCP-GUJARAT
NVBDCP-GUJARAT
 
Malaria elimination framework 2016 2030
Malaria elimination framework 2016 2030Malaria elimination framework 2016 2030
Malaria elimination framework 2016 2030
 
ANTI MALARIA CONTROL PROGRAMME
ANTI MALARIA CONTROL PROGRAMMEANTI MALARIA CONTROL PROGRAMME
ANTI MALARIA CONTROL PROGRAMME
 
National aids control programme
National aids control programmeNational aids control programme
National aids control programme
 

Andere mochten auch

Andere mochten auch (8)

Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Malaria Epidemics : Prevention and Control
Malaria Epidemics : Prevention and ControlMalaria Epidemics : Prevention and Control
Malaria Epidemics : Prevention and Control
 
Malaria program
Malaria programMalaria program
Malaria program
 
Malaria in Bangladesh
Malaria in BangladeshMalaria in Bangladesh
Malaria in Bangladesh
 
public Health in Somalia
public Health in Somaliapublic Health in Somalia
public Health in Somalia
 
About Kala azar in bangladesh
About Kala azar in bangladeshAbout Kala azar in bangladesh
About Kala azar in bangladesh
 
Malaria
MalariaMalaria
Malaria
 
National malaria control programe
National malaria control programeNational malaria control programe
National malaria control programe
 

Ähnlich wie Who's Who in International Malaria Control

Aids architecture emerging issues for discussion
Aids architecture   emerging issues for discussionAids architecture   emerging issues for discussion
Aids architecture emerging issues for discussionAIDS Watch Africa
 
Engage brochure
Engage brochureEngage brochure
Engage brochureclac.cab
 
HFG Peru Final Country Report
HFG Peru Final Country ReportHFG Peru Final Country Report
HFG Peru Final Country ReportHFG Project
 
Day 1 sat presentation re nfm feb 28
Day 1 sat presentation re nfm feb 28 Day 1 sat presentation re nfm feb 28
Day 1 sat presentation re nfm feb 28 clac.cab
 
Sustainability and transition - Nicolas Cantau, The Global Fund
Sustainability and transition - Nicolas Cantau, The Global FundSustainability and transition - Nicolas Cantau, The Global Fund
Sustainability and transition - Nicolas Cantau, The Global FundOECD Governance
 
NFM_master deck
NFM_master deckNFM_master deck
NFM_master deckclac.cab
 
Where To Go From Here: Implementation And The Way Forward
Where To Go From Here:  Implementation And The Way ForwardWhere To Go From Here:  Implementation And The Way Forward
Where To Go From Here: Implementation And The Way ForwardGlobal Risk Forum GRFDavos
 
governance of public health practices globallypptx.pptx
governance of public health practices globallypptx.pptxgovernance of public health practices globallypptx.pptx
governance of public health practices globallypptx.pptxKeirelEdrin
 
The Global Agriculture and Food Security Program
The Global Agriculture and Food Security ProgramThe Global Agriculture and Food Security Program
The Global Agriculture and Food Security ProgramFrancois Stepman
 
Community update 2014
Community update 2014Community update 2014
Community update 2014clac.cab
 
Au roadmap and domestic financing presentation
Au roadmap and domestic financing presentationAu roadmap and domestic financing presentation
Au roadmap and domestic financing presentationAIDS Watch Africa
 
Au roadmap and domestic financing presentation
Au roadmap and domestic financing presentationAu roadmap and domestic financing presentation
Au roadmap and domestic financing presentationAIDS Watch Africa
 
Domestic Resource Mobilisation - Kenya Health Sector
Domestic Resource Mobilisation - Kenya Health SectorDomestic Resource Mobilisation - Kenya Health Sector
Domestic Resource Mobilisation - Kenya Health SectorEmmanuel Mosoti Machani
 
Has call for_proposals_2014_final1
Has call for_proposals_2014_final1Has call for_proposals_2014_final1
Has call for_proposals_2014_final1Andika Wibaskara
 
Demystifying Universal Health Coverage
Demystifying Universal Health CoverageDemystifying Universal Health Coverage
Demystifying Universal Health CoverageHFG Project
 
Monitoring_and_Evaluation_2.pdf
Monitoring_and_Evaluation_2.pdfMonitoring_and_Evaluation_2.pdf
Monitoring_and_Evaluation_2.pdfssusere0ee1d
 

Ähnlich wie Who's Who in International Malaria Control (20)

9 core global-fund_strategy_en1
9 core global-fund_strategy_en19 core global-fund_strategy_en1
9 core global-fund_strategy_en1
 
9 core global-fund_strategy_en1
9 core global-fund_strategy_en19 core global-fund_strategy_en1
9 core global-fund_strategy_en1
 
Aids architecture emerging issues for discussion
Aids architecture   emerging issues for discussionAids architecture   emerging issues for discussion
Aids architecture emerging issues for discussion
 
Engage brochure
Engage brochureEngage brochure
Engage brochure
 
HFG Peru Final Country Report
HFG Peru Final Country ReportHFG Peru Final Country Report
HFG Peru Final Country Report
 
Day 1 sat presentation re nfm feb 28
Day 1 sat presentation re nfm feb 28 Day 1 sat presentation re nfm feb 28
Day 1 sat presentation re nfm feb 28
 
Health system development2
Health system development2Health system development2
Health system development2
 
Sustainability and transition - Nicolas Cantau, The Global Fund
Sustainability and transition - Nicolas Cantau, The Global FundSustainability and transition - Nicolas Cantau, The Global Fund
Sustainability and transition - Nicolas Cantau, The Global Fund
 
NFM_master deck
NFM_master deckNFM_master deck
NFM_master deck
 
Where To Go From Here: Implementation And The Way Forward
Where To Go From Here:  Implementation And The Way ForwardWhere To Go From Here:  Implementation And The Way Forward
Where To Go From Here: Implementation And The Way Forward
 
Chadia presentation 19 nov 2013
Chadia presentation  19 nov 2013Chadia presentation  19 nov 2013
Chadia presentation 19 nov 2013
 
governance of public health practices globallypptx.pptx
governance of public health practices globallypptx.pptxgovernance of public health practices globallypptx.pptx
governance of public health practices globallypptx.pptx
 
The Global Agriculture and Food Security Program
The Global Agriculture and Food Security ProgramThe Global Agriculture and Food Security Program
The Global Agriculture and Food Security Program
 
Community update 2014
Community update 2014Community update 2014
Community update 2014
 
Au roadmap and domestic financing presentation
Au roadmap and domestic financing presentationAu roadmap and domestic financing presentation
Au roadmap and domestic financing presentation
 
Au roadmap and domestic financing presentation
Au roadmap and domestic financing presentationAu roadmap and domestic financing presentation
Au roadmap and domestic financing presentation
 
Domestic Resource Mobilisation - Kenya Health Sector
Domestic Resource Mobilisation - Kenya Health SectorDomestic Resource Mobilisation - Kenya Health Sector
Domestic Resource Mobilisation - Kenya Health Sector
 
Has call for_proposals_2014_final1
Has call for_proposals_2014_final1Has call for_proposals_2014_final1
Has call for_proposals_2014_final1
 
Demystifying Universal Health Coverage
Demystifying Universal Health CoverageDemystifying Universal Health Coverage
Demystifying Universal Health Coverage
 
Monitoring_and_Evaluation_2.pdf
Monitoring_and_Evaluation_2.pdfMonitoring_and_Evaluation_2.pdf
Monitoring_and_Evaluation_2.pdf
 

Mehr von stompoutmalaria

Malaria Policy and Advocacy
Malaria Policy and Advocacy Malaria Policy and Advocacy
Malaria Policy and Advocacy stompoutmalaria
 
Malaria Diagnosis, Treatment, and Drug Resistance
Malaria Diagnosis, Treatment, and Drug ResistanceMalaria Diagnosis, Treatment, and Drug Resistance
Malaria Diagnosis, Treatment, and Drug Resistancestompoutmalaria
 
Introduction to malaria in pregnancy
Introduction to malaria in pregnancyIntroduction to malaria in pregnancy
Introduction to malaria in pregnancystompoutmalaria
 
Malaria Profile: Ethiopia
Malaria Profile: EthiopiaMalaria Profile: Ethiopia
Malaria Profile: Ethiopiastompoutmalaria
 
Malaria Profile: Burkina Faso
Malaria Profile: Burkina FasoMalaria Profile: Burkina Faso
Malaria Profile: Burkina Fasostompoutmalaria
 
Elimination of mother to child transmission of hiv
Elimination of mother to child transmission of hivElimination of mother to child transmission of hiv
Elimination of mother to child transmission of hivstompoutmalaria
 

Mehr von stompoutmalaria (9)

Plasmodium Lifecycle
Plasmodium LifecyclePlasmodium Lifecycle
Plasmodium Lifecycle
 
Malaria Policy and Advocacy
Malaria Policy and Advocacy Malaria Policy and Advocacy
Malaria Policy and Advocacy
 
Malaria Diagnosis, Treatment, and Drug Resistance
Malaria Diagnosis, Treatment, and Drug ResistanceMalaria Diagnosis, Treatment, and Drug Resistance
Malaria Diagnosis, Treatment, and Drug Resistance
 
Introduction to malaria in pregnancy
Introduction to malaria in pregnancyIntroduction to malaria in pregnancy
Introduction to malaria in pregnancy
 
Malaria Profile: Ethiopia
Malaria Profile: EthiopiaMalaria Profile: Ethiopia
Malaria Profile: Ethiopia
 
Malaria Profile: Burkina Faso
Malaria Profile: Burkina FasoMalaria Profile: Burkina Faso
Malaria Profile: Burkina Faso
 
Elimination of mother to child transmission of hiv
Elimination of mother to child transmission of hivElimination of mother to child transmission of hiv
Elimination of mother to child transmission of hiv
 
Malaria Sales Pitch
Malaria Sales PitchMalaria Sales Pitch
Malaria Sales Pitch
 
Radio Production
Radio ProductionRadio Production
Radio Production
 

Kürzlich hochgeladen

systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 

Kürzlich hochgeladen (20)

systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 

Who's Who in International Malaria Control

  • 1. Who’s Who in International Malaria Control Peace Corps Malaria Initiative for Africa Boot Camp DEBBIE GUEYE PMI/SENEGAL RESIDENT ADVISOR FEBRUARY 7, 2012
  • 2. Objectives  Understand how the different components of PMI (USAID, HHS, CDC) work together and with other agencies;  Be familiar with the major international actors in malaria control  Understand how the Global Fund application process works  Discuss challenges and opportunities in coordination
  • 3. The Major Actors  President’s Malaria Initiative  The Global Fund  Roll Back Malaria Partnership  World Health Organization/Global Malaria Program
  • 4. President’s Malaria Initiative  Launched in June 2005 as a five-year, $1.2 billion initiative to rapidly scale up malaria prevention and treatment interventions  2008 Lantos-Hyde Act: funding extended through Fiscal Year 2014  Managed by USAID in coordination with the Department of Health and Human Services (CDC), the Department of State, and the White House  17 Countries: Angola, Benin, DRC, Ethiopia, Ghana, Kenya, Liberia, Madagascar, Malawi, Mali, Mozambique, Nigeria, Rwanda, Senegal, Tanzania, Uganda, Zambia www.pmi.gov
  • 5. PMI Principles  PMI aligns its activities with host country malaria control strategies and coordinates closely with international partners, non-governmental organizations, community groups, and the private sector  PMI is a core component of the Global Health Initiative (GHI), along with HIV/AIDS, and tuberculosis. Adherence to GHI core principles • encouraging country ownership • increasing impact and efficiency and investing in country-led plans through strategic coordination and health systems and programmatic integration • strengthening and leveraging key • implementing a woman- and girl- partnerships, multilateral centered approach organizations, and private contributions • improving monitoring and • promoting research and evaluation innovation
  • 6. PMI Goal and Interventions  Goal: reduce malaria-related mortality by 70% in the original 15 countries by the end of 2015, by reaching 85% of the most vulnerable groups – primarily pregnant women and children under five years old – with proven preventive and therapeutic interventions  PMI supports four key intervention strategies for malaria prevention and control:  Spraying approved, long-lasting insecticides on the interior walls of homes (indoor residual spraying)  Promotion and distribution of long-lasting insecticide-treated bednets (LLINs)  Training for medical personnel and community health workers to improve malaria diagnosis and effective treatment  Prevention among pregnant women with prophylactic drugs during prenatal care (intermittent preventive treatment)
  • 7. PMI Country Operations  2 Resident Advisors in-country: USAID and CDC  Provide technical support to NMCP and oversee PMI-funded programs  Annual Malaria Operational Plan (MOP)  Developed collaboratively with NMCP and local stakeholders  Background, progress, planned activities  Budget by activity and implementing mechanism  Reviewed and approved by USAID-CDC Technical Working Group (TWG), followed by inter-agency steering group (ISG) that includes HHS, OMB, White House  Any proposed changes must be described in reprogramming memo, approved by PMI Coordinator
  • 8. PMI Country Operations  Implementation mechanisms  Bilateral: conceived, funded and managed from the local USAID Mission  Field Support: conceived by USAID/Washington, some central funding and overall management; countries “buy in” and manage local interventions  Funds allocated through competitive bidding processes  Projects generally run 5 years  Advance planning for funds that are slow to come
  • 9. The Global Fund to Fight AIDS, Tuberculosis and Malaria  Created in 2002 to dramatically increase resources to fight three of the world's most devastating diseases, and to direct those resources to areas of greatest need  Partnership between governments, civil society, the private sector and affected communities represents an innovative approach to international health financing  Model based on the concepts of country ownership and performance-based funding, which means that people in countries implement their own programs based on their priorities and the Global Fund provides financing on the condition that verifiable results are achieved http://www.theglobalfund.org
  • 10. Global Fund Guiding Principles  Operate as a financial instrument, not an implementing entity  Make available and leverage additional financial resources  Support programs that evolve from national plans and priorities  Operate in a balanced manner in terms of different regions, diseases and interventions  Pursue an integrated and balanced approach to prevention and treatment  Evaluate proposals through independent review process (TRP)  Operate with transparency and accountability
  • 11. Global Fund Core Structures - Central  Global Fund Secretariat:  manages the grant portfolio, including screening proposals submitted, issuing instructions to disburse money and implementing performance-based funding of grants  tasked with executing Board policies; resource mobilization; providing strategic, policy, financial, legal and administrative support; and overseeing monitoring and evaluation  based in Geneva, no staff located outside its headquarters
  • 12. Global Fund Core Structures - Central  Technical Review Panel (TRP):  independent group of international experts in the three diseases and cross-cutting issues (health systems, M&E, etc.)  meets regularly to review proposals based on technical criteria and provide funding recommendations to the Board
  • 13. Global Fund Core Structures - Central  Global Fund Board  composed of representatives from donor and recipient gov-ernments, civil society, the private sector, private foundations, and communities living with and affected by the diseases  responsible for the organization’s gover­nance, including establishing strategies and policies, making funding decisions and setting budgets  works to advocate and mobilize resources for the organization  Global Fund Trustee  manages the organization’s money, which includes making payments to recipients at the instruction of the Secretariat  The Trustee is cur-rently the World Bank
  • 14. Global Fund Core Structures - Country  Country Coordinating Mechanism (CCM)  com-posed of all key stakeholders for the three diseases.  Demonstrates commitment to local ownership and participatory decision-making  includes representatives from public and private sectors, including governments, multilateral or bilateral agencies, non-governmental organizations, academic institutions, private businesses and people living with the diseases  does not handle Global Fund financing itself
  • 15. Global Fund Core Structures - Country  CCM Core Functions  coordinate the development and submission of national proposals  nominate the Principal Recipient  oversee implementation of the approved grant and submit requests for funding  approve any reprogramming and submit requests for continued funding  ensure linkages and consistency between Global Fund grants and other national health and development programs
  • 16. Global Fund Core Structures - Country  The Global Fund signs a legal grant agreement with a Principal Recipient (PR)  designated by the CCM  receives Global Fund financing directly, and uses it to implement prevention, care and treatment programs or passes it on to other organizations (sub-recipients) who provide those services  makes regular requests for additional disbursements from the Global Fund based on demonstrated progress towards the intended results
  • 17. Global Fund Core Structures - Country  Local Fund Agents (LFAs)  firms contracted by Global Fund to monitor implementation (selected through competitive bidding)  responsible for provid-ing recommendations to the Secretariat on the capacity of the entities chosen to man-age Global Fund financing and on the soundness of regular requests for the disburse-ment of funds and result reports submitted by PRs.
  • 18. Operations  Annual call for proposals (“rounds”)  GF follows the principles of performance-based funding in making funding decisions. Ensure that investments are made only where grant funding is managed and spent effectively on programs that achieve impact  Grants initially approved for two years (Phase 1) and renewed for up to three additional years (Phase 2) based on performance  Funding disbursed incrementally every three to six months throughout the grant's lifespan, and each disbursement is based on performance
  • 19. High Level Independent Review Panel Recommendations 1. Turn the Page from Emergency to Sustainable Response 1.1 No Amnesty for Fraud, but Focus Oversight on More-Recent Rounds of Grants 1.2 Strengthen the Relationship between the Secretariat and the Inspector General 2. Declare a Doctrine of Risk and Manage to it 2.1 Adopt a New Risk-Management Framework 2.2 Redefine “Country Ownership” 2.3 Apply the Risk-Management Framework to the Existing Portfolio 3. Strengthen Internal Governance 3.1 Focus the Global Fund’s Board on Management, Strategy and Risk- Management 3.2 Re-purpose the Committees (Investment, Audit, Finance) 3.3 Create an Executive Staff to Support the Global Fund’s Board
  • 20. High Level Independent Review Panel Recommendations (2) 4. Streamline the Grant-Approval Process 4.1 Institute a Two-Stage Grant Process 4.2 Apply Risk-Differentiated Grant Processes and Requirements 5. Empower Middle-Management’s Decision-Making 5.1 Establish a Chief Risk Officer 5.2 Align the Staffing Pattern to Bolster Grant-Management 5.3 Empower the Fund Portfolio Managers 5.4 Streamline and Expand the Country Teams 5.5 Reinforce the Executive Management Team 5.6 Leverage the Investment in the Local Fund Agents 5.7 Define and Clarify the Role and Responsibilities of External Auditors 6. Get Serious About Results 6.1 Measure Outcomes, Not Inputs 6.2 Focus on Quality and Value, Rather than Quantity 6.3 Consolidate the Reform Agenda
  • 21. Roll Back Malaria (RBM) Partnership  Lead international forum for malaria stakeholders to coordinate implementation activity, formulate and promote international policy positions relating to malaria, and to promote advocacy for malaria prevention, control, and fund- raising.  Launched in 1998 by WHO, UNICEF, UNDP and the World Bank, in an effort to provide a coordinated global response to the disease.  Led by the Executive Director, and served by a Secretariat that is hosted by the World Health Organization in Geneva. The Secretariat works to facilitate policy coordination at a global level. http://www.rollbackmalaria.org
  • 22. Global Coordination  The RBM Partnership is the global framework to implement coordinated action against malaria  mobilizes for action and resources and forges consensus among partners  is comprised of more than 500 partners, including malaria endemic countries, their bilateral and multilateral development partners, the private sector, nongovernmental and community-based organizations, foundations, and research and academic institutions  RBM’s overall strategy aims to reduce malaria morbidity and mortality by reaching universal coverage and strengthening health systems. The Global Malaria Action Plan defines two stages of malaria control: (1) scaling-up for impact (SUFI) of preventive and therapeutic interventions, and (2) sustaining control over time.
  • 23. RBM Organization  Working Groups  RBM Sub-Regional Networks  Malaria Advocacy (SRNs):  Communication  Central Africa  Harmonization: The HWG facilitates and harmonizes  East Africa partners' support in response to countries identified needs  Southern Africa and supports the establishment of the 'three  West Africa ones' principles for malaria at country level.  Identify, coordinate, and  Resources respond to requests for  Vector Control technical assistance for the  Procurement and Supply scale-up of malaria control Management and treatment interventions  Case Management  Monitoring and Evaluation  Malaria in Pregnancy
  • 24. World Health Organization/ Global Malaria Program (GMP)  Responsible for malaria surveillance, monitoring and evaluation, policy and strategy formulation, technical assistance, and coordination of WHO's global efforts to fight malaria  As part of the World Health Organization, convenes experts to review evidence and set global policies  GMP's policy advice provides the benchmark for national malaria programmes and multilateral funding agencies www.who.int/malaria
  • 25. GMP Strategic Advantage  Unique position uniting high levels of expertise – and WHO's field presence in all regions and all malaria- endemic countries of the world – ensures harmonized policy advice and the critical technical assistance necessary to effect concrete and sustainable successes at global level  Activities focused on providing an integrated solution to the various epidemiological and operational challenges  Promotes sound, evidence-based and locally appropriate strategies.  Helps countries reach the most vulnerable populations and ensure that needed interventions take into account social, economic and environmental realities.
  • 26. GMP Technical Assistance  Supports national malaria programmes worldwide and provides technical assistance at country level on five main topics:  diagnosis and treatment (diagnostic tools, medicines, patient management, quality assurance, supply chain management)  vector control and preventive measures (mosquito control; reducing the risk of infection for local populations and international travellers)  elimination of malaria (expanding the malaria-free areas of the world)  surveillance, monitoring and evaluation (generating data for decision making, quality assurance)  research (improving the tools to combat malaria, and the way we use them)  Malaria National Professional Officer (NPO) in country offices  WHO/AFRO: regional headquarters in Brazzaville, Congo
  • 27. Key Technical Documents/Reports  World Malaria Report  Malaria Treatment Guidelines  Anitmalarial efficacy and drug resistance: 2000-2010  Global Plan for Artemisinin Resistance Containment  Good Procurement Practices for Artemisinin-based antimalarial medicines  Good Practices for Selecting and Procuring Rapid Diagnostic Tests for Malaria  RDT Product Testing Results  Indoor Residual Spraying
  • 28. WHOPES (WHO Pesticide Evaluation Scheme)  Set up in 1960, WHOPES promotes and coordinates the testing and evaluation of pesticides for public health  Representatives of governments, manufacturers of pesticides and pesticide application equipment, WHO Collaborating Centres and research institutions, and other WHO programmes  Four-phase evaluation and testing programme, studying the safety, efficacy and operational acceptability of public health pesticides and developing specifications for quality control and international trade  WHOPES collects, consolidates, evaluates and disseminates information on the use of pesticides for public health.  Recommendations facilitate the registration of pesticides by Member States.
  • 29.
  • 30. Challenges and Opportunities in Coordination  Among these actors, PMI is only one that has both money and people on the ground  Global Fund: money, no people  RBM: people (but regional focus), no money  WHO: people, no money  WHO is the technical leader for malaria control programs, personnel very well respected  Global Fund: It’s complicated  Objective: to have all partners supporting the NMCP plan and strategies  Challenge: partners have their own agendas